The Timing of Surgery and Symptom Resolution in Patients Undergoing Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Disk Disease and Radiculopathy

被引:14
|
作者
Villavicencio, Alan T. [1 ,2 ]
Nelson, E. Lee [1 ]
Rajpal, Sharad
Burneikiene, Sigita [1 ,2 ]
机构
[1] Boulder Neurosurg Associates, 4743 Arapahoe Ave,Suite 202, Boulder, CO 80303 USA
[2] Justin Parker Neurol Inst, Boulder, CO USA
来源
CLINICAL SPINE SURGERY | 2017年 / 30卷 / 06期
关键词
clinical outcomes; duration of symptoms; prospective; clinical study; radiculopathy; transforaminal lumbar interbody fusion (TLIF); OUTCOMES-RESEARCH-TRIAL; SPINAL STENOSIS; CONSERVATIVE TREATMENT; PROSPECTIVE COHORT; PROGNOSTIC-FACTORS; HERNIATION; DURATION; MANAGEMENT; SCIATICA; PAIN;
D O I
10.1097/BSD.0000000000000392
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Success rates of surgical interventions for lumbar disorders vary significantly depending on multiple factors and, among them, the duration of symptoms. It is not clear whether there is a "cutoff" time when decompression and fusion surgery becomes less effective in the conditions with chronic nerve root compression symptomatology. The main objective of this study was to analyze whether duration of symptoms has any effect on clinical outcomes and primarily resolution of radicular pain symptoms due to degenerative disk disease and stenosis with spondylolisthesis in patients undergoing transforaminal lumbar interbody fusion (TLIF). Methods: The prospective observational study was performed. Eighty-four patients with radicular symptoms due to degenerative disk disease and stenosis with spondylolisthesis with no previous fusion surgeries and undergoing 1- to 3-level TLIF surgery were enrolled. Fifteen patients (18%) were lost to follow-up and were excluded from this analysis leaving a total of 69 patients. Standardized questionnaires were used to analyze clinical outcomes and were administered preoperatively within 3 months of scheduled surgery, and postoperatively at 3, 6, 12, and 24 months. To emphasize the change in clinical outcome scores, the relevant scores were calculated as the ratio of minimal clinically important difference values and change scores. The change scores were calculated by subtracting the postoperative scores from the baseline scores. Multiple regression analyses were conducted to examine the relationship of the duration of symptoms and relevant minimal clinically important difference ratio values while controlling for independent variables. Further, a comparison between 2 groups of patients was performed to analyze the changes of clinical outcomes for the patients who underwent fusion within <24 months versus >= 24 months. Results: It was determined that the duration of symptoms was a significant predictor of better leg pain resolution (P=0.018), but not back pain resolution (P=0.27), or improvement in ODI (P=0.10) and SF-36 PCS scores (P=0.19). The patients with shorter duration of symptoms had significantly better radicular symptom resolution (P=0.032) compared with patients who waited at least 24 months or longer to undergo fusion. Conclusions: A shorter duration of symptoms was found to be a statistically significant predictor for better resolution of radicular symptoms in patients undergoing TLIF for painful degenerative disk disease and stenosis with spondylolisthesis.
引用
收藏
页码:E765 / E769
页数:5
相关论文
共 50 条
  • [31] Transforaminal Lumbar Interbody Fusion Versus Anterior Lumbar Interbody Fusion as an Adjunct to Posterior Instrumented Correction of Degenerative Lumbar Scoliosis
    Crandall, Dennis G.
    Revella, Jan
    SPINE, 2009, 34 (20) : 2126 - 2133
  • [32] Endoscopic Lumbar Interbody Fusion, Minimally Invasive Transforaminal Lumbar Interbody Fusion, and Open Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Degenerative Diseases: A Systematic Review and Network Meta-Analysis
    Hu, Xijian
    Yan, Lei
    Jin, Xinjie
    Liu, Haifeng
    Chai, Jing
    Zhao, Bin
    GLOBAL SPINE JOURNAL, 2024, 14 (01) : 295 - 305
  • [33] Minimally invasive transforaminal lumber interbody fusion and degenerative lumbar spine disease
    Tsahtsarlis, Antonio
    Wood, Martin
    EUROPEAN SPINE JOURNAL, 2012, 21 (11) : 2300 - 2305
  • [34] Minimally invasive transforaminal lumber interbody fusion and degenerative lumbar spine disease
    Antonio Tsahtsarlis
    Martin Wood
    European Spine Journal, 2012, 21 : 2300 - 2305
  • [35] Incidence and Risk Factors for Adjacent Segment Disease After Transforaminal Lumbar Interbody Fusion in Patients with Lumbar Degenerative Diseases
    Ye, Jiawen
    Yang, Sizhen
    Wei, Zihan
    Cai, Chenhui
    Zhang, Ying
    Qiu, Hao
    Chu, Tongwei
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 8185 - 8192
  • [36] Bracing Following Transforaminal Lumbar Interbody Fusion is not Necessary for Patients With Degenerative Lumbar Spine Disease A Prospective, Randomized Trial
    Yao, Yu-Cheng
    Lin, Hsi-Hsien
    Chang, Ming-Chau
    CLINICAL SPINE SURGERY, 2018, 31 (09): : E441 - E445
  • [37] Full Endoscopic Lumbar Transforaminal Interbody Fusion in DDD Lumbar Degenerative Disc Disease: A Latest Technique
    Sharma, Manoj
    Chhawra, Sanjay
    Jain, Raman
    Sharma, Sandeep
    INTERNATIONAL JOURNAL OF SPINE SURGERY, 2021, 14 : S71 - S77
  • [38] Minimally invasive transforaminal lumbar interbody fusion for dual-segment lower lumbar degenerative disease
    Wang, Wei
    Wang, Zhangfu
    Hong, Zhenghua
    Chen, Haixiao
    VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES, 2018, 13 (04) : 525 - 532
  • [39] Minimally Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Spine
    Chaudhary, Kshitij S.
    Groff, Michael W.
    TECHNIQUES IN ORTHOPAEDICS, 2011, 26 (03) : 146 - 155
  • [40] Functional outcome of transforaminal lumbar interbody fusion (TLIF) for degenerative disc disease and spondylolisthesis of lumbar spine
    Satar, Abdul
    Inam, Muhammad
    Hassan, Waciar
    Arif, Muhammad
    RAWAL MEDICAL JOURNAL, 2012, 37 (03): : 292 - 296